Abstract:Metastasis is a lethal disease of cancer, spreading from primary tumors to the bloodstream as circulating tumor cells (CTCs), which disseminate to distant organs at low efficiency for secondary tumor regeneration, thereby contributing to unfavorable patient outcomes. The detection of dynamic CTC alterations can be indicative of cancer progression (residual cancer, aggressiveness, therapy resistance) or regression (therapy response), serving as biomarkers for diagnoses and prognoses. CTC heterogeneity is impacted by both intrinsic oncogenic changes and extrinsic microenvironmental factors (e.g. the immune system and circadian rhythm), altering the genomic/genetic, epigenomic/epigenetic, proteomic, post-translational, and metabolomic landscapes. In addition to homeostatic dynamics, regenerative stemness, and metabolic plasticity, a newly discovered feature of CTCs that influences metastatic outcomes is its intercellular clustering. While the dogma suggests that CTCs play solo as single cells in the circulation, CTCs can orchestrate with other CTCs or white blood cells to form homotypic or heterotypic multi-cellular clusters, with 20–100 times enhanced metastatic potential than single CTCs. CTC clusters promote cell survival and stemness through DNA hypomethylation and signaling pathways activated by clustering-driving proteins (CD44, CD81, ICAM1, Podocalyxin, etc). Heterotypic CTC clusters may protect CTCs from immune cell attacks if not being cleared by cytotoxic immune cells. This chapter mainly focused on CTC biology related to multi-omic features and metastatic outcomes. We speculate that CTCs could guide therapeutic targeting and be targeted specifically by anti-CTC therapeutics to reduce or eliminate cancer and cancer metastasis.

Cell–Cell Interactions Drive Metastasis of Circulating Tumor Microemboli

Role of Epithelial-to-Mesenchymal Transition for the Generation of Circulating Tumors Cells and Cancer Cell Dissemination

Platelets and circulating (tumor) cells: partners in promoting metastatic cancer

CTC-neutrophil interaction: A key driver and therapeutic target of cancer metastasis

Circulating tumor cell-blood cell crosstalk: Biology and clinical relevance

Better together: circulating tumor cell clustering in metastatic cancer

Circulating Tumour Cell Clusters: Isolation, Biological Significance and Therapeutic Implications

Circulating tumor cell clusters: Insights into tumour dissemination and metastasis

Bring along your friends: Homotypic and heterotypic circulating tumor cell clustering to accelerate metastasis

A narrative review of circulating tumor cells clusters: A key morphology of cancer cells in circulation promote hematogenous metastasis

Multi-omic features and clustering phenotypes of circulating tumor cells associated with metastasis and clinical outcomes

Key Characteristics of Circulating Tumor Cell Clusters and Implications for Cancer Metastases

Epithelial-to-mesenchymal transition, circulating tumor cells and cancer metastasis: Mechanisms and clinical applications

Mechanobiology and survival strategies of circulating tumor cells: a process towards the invasive and metastatic phenotype

Never Travel Alone: The Crosstalk of Circulating Tumor Cells and the Blood Microenvironment

Tumor-derived cell-free DNA and circulating tumor cells: partners or rivals in metastasis formation?

Interaction Between Circulating Cancer Cells and Platelets: Clinical Implication

Biophysical interactions between components of the tumor microenvironment promote metastasis

Platelets Involved Tumor Cell EMT During Circulation: Communications and Interventions

Circulating Tumor Cells in Cancer Patients: Developments and Clinical Applications for Immunotherapy

Survival mechanisms of circulating tumor cells and their implications for cancer treatment